社債
以下は、Novo Nordisk A/S Class Bの社債をワースト利回り順に並べたリストです。投資家は、市場の変動が激しい時期において、比較的安定した投資先として社債を選ぶ傾向にあります。価格、利回り、その他の指標を分析して、信頼できる投資先を見つけましょう。
シンボル | YTW % | 価格 % | クーポン % | 満期日 | 発行残高 | 額面金額 | S&P格付け | フィッチ格付け | 発行体 |
|---|---|---|---|---|---|---|---|---|---|
 XS323295972Novo Nordisk Finance (Netherlands) BV 4.0% 20-NOV-2045 | 4.36% | 95.26% | 4.000% | 2045-11-20 | 750 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS323295590Novo Nordisk Finance (Netherlands) BV 3.625% 20-FEB-2038 | 4.02% | 96.21% | 3.625% | 2038-02-20 | 750 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS300255582Novo Nordisk Finance (Netherlands) BV 3.625% 27-MAY-2037 | 3.94% | 96.94% | 3.625% | 2037-05-27 | 1.25 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS323294453Novo Nordisk Finance (Netherlands) BV 3.375% 20-FEB-2035 | 3.82% | 96.76% | 3.375% | 2035-02-20 | 600 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS282046075Novo Nordisk Finance (Netherlands) BV 3.375% 21-MAY-2034 | 3.75% | 97.45% | 3.375% | 2034-05-21 | 1.35 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS300255353Novo Nordisk Finance (Netherlands) BV 3.125% 27-MAY-2033 | 3.60% | 96.77% | 3.125% | 2033-05-27 | 900 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS323293716Novo Nordisk Finance (Netherlands) BV 3.0% 20-FEB-2032 | 3.52% | 97.27% | 3.000% | 2032-02-20 | 600 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS282045567Novo Nordisk Finance (Netherlands) BV 3.25% 21-JAN-2031 | 3.47% | 99.10% | 3.250% | 2031-01-21 | 1 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS300255329Novo Nordisk Finance (Netherlands) BV 2.875% 27-AUG-2030 | 3.34% | 97.82% | 2.875% | 2030-08-27 | 1 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS282045460Novo Nordisk Finance (Netherlands) BV 3.125% 21-JAN-2029 | 3.23% | 99.72% | 3.125% | 2029-01-21 | 1 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS244124704Novo Nordisk Finance (Netherlands) BV 1.375% 31-MAR-2030 | 3.21% | 93.70% | 1.375% | 2030-03-31 | 500 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS323292124Novo Nordisk Finance (Netherlands) BV 2.5% 20-FEB-2029 | 3.17% | 98.31% | 2.500% | 2029-02-20 | 650 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS234803042Novo Nordisk Finance (Netherlands) BV 0.125% 04-JUN-2028 | 3.13% | 94.64% | 0.125% | 2028-06-04 | 650 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS300255299Novo Nordisk Finance (Netherlands) BV 2.375% 27-MAY-2028 | 3.11% | 98.24% | 2.375% | 2028-05-27 | 1.45 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS244933017Novo Nordisk Finance (Netherlands) BV 1.125% 30-SEP-2027 | 2.90% | 97.96% | 1.125% | 2027-09-30 | 500 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
 NNO263Novo Nordisk A/S 1.6325% 11-JUN-2041 | 1.63% | 99.80% | 1.633% | 2041-06-11 | 175 M CHF | 100,000.00 CHF | AA | — | Novo Nordisk A/S |
| CH157281997Novo Nordisk A/S 1.315% 11-JUN-2036 | 1.34% | 99.45% | 1.315% | 2036-06-11 | 335 M CHF | 100,000.00 CHF | AA | — | Novo Nordisk A/S |
| CH157281996Novo Nordisk A/S 0.9425% 11-JUN-2032 | 0.99% | 99.12% | 0.943% | 2032-06-11 | 400 M CHF | 100,000.00 CHF | AA | — | Novo Nordisk A/S |
| NNO26Novo Nordisk A/S 0.575% 11-JUN-2029 | 0.67% | 100.05% | 0.575% | 2029-06-11 | 180 M CHF | 100,000.00 CHF | AA | — | Novo Nordisk A/S |
| XS300255213Novo Nordisk Finance (Netherlands) BV FRN 27-MAY-2027 | — | 99.66% | 2.504% | 2027-05-27 | 1.4 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |
| XS323292027Novo Nordisk Finance (Netherlands) BV FRN 20-NOV-2027 | — | 99.90% | 2.419% | 2027-11-20 | 650 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |